Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

THC Biomed Intl Ltd C.THC

Alternate Symbol(s):  THCBF

THC Biomed Intl Ltd. is a Canada-based cannabis producer. The Company’s principal business is the production and sale of cannabis through THC BioMed Ltd., which is a small batch Licensed Producer as regulated by the Cannabis Act which regulates the production, distribution, and possession of cannabis for both medical and adult recreational access in Canada. The Company’s biological assets consist of cannabis plants (mother plants and clones for growth); resin; oil; harvested marijuana flowers prior to completion of the drying, grading and testing processes; and edible concentrate. The Company operates in a single reportable segment being the cultivation and sale of cannabis. Its subsidiaries include THC BioMed Ltd., Clone Shipper Ltd., THC BioMed Victoria Falls Ltd., THC2GO Dispensaries Ltd. (THC2GO), and THC BioMed Lesotho Ltd. (THC Lesotho). Clone Shipper Ltd. owns all rights to the Clone Shipper product used to transport live plants.


CSE:THC - Post by User

Bullboard Posts
Post by JRSDIRECTon Aug 23, 2018 1:25pm
128 Views
Post# 28506884

Two Scenarios

Two ScenariosAnnoucing an undefined supply agreement

Scenario #1
Ontario turns to THC as THC states they are the largest, leading medicinal supplier in Canada. So Ontario now in boardroom discussion turns to THC as states you will supply through our distribution chain to hospitals, hostices, etc.

Manulife Insurance recently announced the medicinal cannabis will be offered to corporate benefit packages as an option. We Ontario government, will regulate Manulife, and their suppliers to ensure 'medicinal' cannabis is supplied.

THC has announced their Ontario deal - SP barely ticks because, well, we fellow investors knew they were supply something so thank you for telling what it is and let's move on.


Scenario #2
The supply arrangement for THC is extremely minimal. Scraps after the pride has their feast (sorry stupid National Geographic analogy)

THC has announced their Ontario deal - far, far, far below expetations.. SP falls like a stone in the lake (another Nature related analogy, sorry for that).


Personally call it and me what you will, I lean on the side of defined agreements that as an investor I can monetize and derive future earnings from which allow me to derive a price to earning ratios, evaluate that ratio to the industry, and determine in the SP is below, fair, or above earnings value - sell with above, hold when fair, buy when below.

Don't have facebook and never will, don't care what people are doing and up to next socially, but put some numbers in it and you have my undevoted attention.
Bullboard Posts